Home › Funds › MILFORD FUNDS LTD › VRTX

MILFORD FUNDS LTD position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

MILFORD FUNDS LTD reported holding 62,667 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$32.8M, representing 0.48% of its reported portfolio and ranking #50 among its reported holdings. MILFORD FUNDS LTD first reported this position in Q3 2026.

Latest position (Q3 2026)62.67K sh
Reported value held$32.76M
Portfolio Weight0.48%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How MILFORD FUNDS LTD's VRTX position evolved

MILFORD FUNDS LTD first disclosed a stake in VRTX in Q3 2026 at 62,667 shares (US$32.8M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 62.67K $32.76M New

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has MILFORD FUNDS LTD held VRTX?

MILFORD FUNDS LTD has disclosed VRTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is MILFORD FUNDS LTD's current position in VRTX?

As of Q3 2026, MILFORD FUNDS LTD holds 62.67K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $32.76M, representing 0.48% of its reported portfolio and ranking #50.

Has MILFORD FUNDS LTD been buying or selling VRTX?

In the latest 13F filing (Q3 2026), MILFORD FUNDS LTD newly opened its position in VRTX.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.